Embolization of Brain Arteriovenous Malformations With Versus Without Onyx Before Stereotactic Radiosurgery
Language English Country United States Media print
Document type Journal Article
PubMed
32860409
DOI
10.1093/neuros/nyaa370
PII: 5898932
Knihovny.cz E-resources
- Keywords
- Arteriovenous malformation, Embolization, Endovascular, Stereotactic radiosurgery, Stroke,
- MeSH
- Adult MeSH
- Intracranial Arteriovenous Malformations therapy MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Polyvinyls therapeutic use MeSH
- Radiosurgery * MeSH
- Retrospective Studies MeSH
- Embolization, Therapeutic methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- ethylene-vinyl alcohol copolymer MeSH Browser
- Polyvinyls MeSH
BACKGROUND: Embolization of brain arteriovenous malformations (AVMs) using ethylene-vinyl alcohol copolymer (Onyx) embolization may influence the treatment effects of stereotactic radiosurgery (SRS) differently than other embolysates. OBJECTIVE: To compare the outcomes of pre-SRS AVM embolization with vs without Onyx through a multicenter, retrospective matched cohort study. METHODS: We retrospectively reviewed International Radiosurgery Research Foundation AVM databases from 1987 to 2018. Embolized AVMs treated with SRS were selected and categorized based on embolysate usage into Onyx embolization (OE + SRS) or non-Onyx embolization (NOE + SRS) cohorts. The 2 cohorts were matched in a 1:1 ratio using de novo AVM features for comparative analysis of outcomes. RESULTS: The matched cohorts each comprised 45 patients. Crude AVM obliteration rates were similar between the matched OE + SRS vs NOE + SRS cohorts (47% vs 51%; odds ratio [OR] = 0.837, P = .673). Cumulative probabilities of obliteration were also similar between the OE + SRS vs NOE + SRS cohorts (subhazard ratio = 0.992, P = .980). Rates of post-SRS hemorrhage, all-cause mortality, radiation-induced changes, cyst formation, and embolization-associated complications were similar between the matched cohorts. Sensitivity analysis for AVMs in the OE + SRS cohort embolized with Onyx alone revealed a higher rate of asymptomatic embolization-associated complications in this subgroup compared to the NOE + SRS cohort (36% vs 15%; OR = 3.297, P = .034), but the symptomatic complication rates were similar. CONCLUSION: Nidal embolization using Onyx does not appear to differentially impact the outcomes of AVM SRS compared with non-Onyx embolysates. The embolic agent selected for pre-SRS AVM embolization should reflect both the experience of the neurointerventionalist and target of endovascular intervention.
Department of Neurological Surgery University of Virginia Charlottesville Virginia
Department of Neurosurgery Centre de Recherche du CHUS Université de Sherbrooke Sherbrooke Canada
Department of Neurosurgery Na Homolce Hospital Prague Czech Republic
Department of Neurosurgery New York University New York New York
Department of Neurosurgery Pennsylvania State University Hershey Pennsylvania
Department of Neurosurgery Taipei Veterans General Hospital Taipei Taiwan
Department of Neurosurgery The Jewish Hospital Cincinnati Ohio
Department of Neurosurgery University of Louisville Louisville Kentucky
Department of Neurosurgery University of Pennsylvania Philadelphia Pennsylvania
Department of Neurosurgery University of Puerto Rico San Juan Puerto Rico
Department of Neurosurgery West Virginia University Morgantown West Virginia
Department of Radiation Oncology Pennsylvania State University Hershey Pennsylvania
Department of Radiation Oncology The Mayo Clinic Jacksonville Florida
Department of Radiation Oncology University of Louisville Louisville Kentucky
References provided by Crossref.org
Treatment of Brain Arteriovenous Malformations